IRIS
PISATURO, Mariantonietta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.836
NA - Nord America 2.817
AS - Asia 555
Continente sconosciuto - Info sul continente non disponibili 6
AF - Africa 5
SA - Sud America 3
OC - Oceania 1
Totale 6.223
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.813
IE - Irlanda 1.298
DE - Germania 339
IT - Italia 317
UA - Ucraina 308
SG - Singapore 275
GB - Regno Unito 251
CN - Cina 169
FI - Finlandia 99
SE - Svezia 79
GR - Grecia 75
TR - Turchia 64
FR - Francia 27
BE - Belgio 15
KR - Corea 14
CZ - Repubblica Ceca 9
IN - India 9
HK - Hong Kong 8
EU - Europa 6
IR - Iran 6
NL - Olanda 6
LT - Lituania 3
AT - Austria 2
BD - Bangladesh 2
CD - Congo 2
CM - Camerun 2
ES - Italia 2
JP - Giappone 2
MX - Messico 2
RS - Serbia 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
CA - Canada 1
EC - Ecuador 1
ID - Indonesia 1
IL - Israele 1
KZ - Kazakistan 1
MD - Moldavia 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PL - Polonia 1
RO - Romania 1
TN - Tunisia 1
TW - Taiwan 1
VE - Venezuela 1
VN - Vietnam 1
Totale 6.223
Salva come PNG Salva come JPEG
Città #
Dublin 1.298
Jacksonville 473
Chandler 438
Santa Clara 411
Singapore 182
Bremen 179
Princeton 177
Roxbury 147
Cambridge 120
New York 89
Ann Arbor 73
Caserta 70
Ashburn 65
Medford 58
Boardman 55
Beijing 49
Wilmington 46
Woodbridge 39
Munich 36
San Mateo 33
Naples 28
Des Moines 26
Washington 26
Nanjing 17
Helsinki 16
Mountain View 16
Brussels 15
Napoli 15
Seoul 14
Düsseldorf 12
Jinan 12
Los Angeles 10
Brno 9
Auburn Hills 8
Grafing 8
Hong Kong 8
Milan 8
Istanbul 7
Lappeenranta 7
Rome 7
Ariano Irpino 6
Houston 6
Shenyang 6
Zhengzhou 6
Kunming 5
Tianjin 5
Aversa 4
Changsha 4
Haikou 4
Hangzhou 4
Jiaxing 4
Leawood 4
Nanchang 4
San Lazzaro di Savena 4
San Nicola la Strada 4
Venice 4
Zanjan 4
Dearborn 3
Frattamaggiore 3
Guangzhou 3
Hanover 3
Hebei 3
Monte San Pietro 3
Sacramento 3
Seattle 3
Shanghai 3
Taiyuan 3
Amsterdam 2
Angri 2
Barlassina 2
Capua 2
Chandigarh 2
Chittagong 2
Elice 2
Ercolano 2
Genoa 2
Hefei 2
Kinshasa 2
Limbiate 2
Madrid 2
Marano Di Napoli 2
Marco 2
Norwalk 2
Paris 2
Portici 2
Pozzuoli 2
Putignano 2
Rockville 2
Sermoneta 2
Tappahannock 2
Tokyo 2
Torre Del Greco 2
Vienna 2
Yaoundé 2
Aci Sant'Antonio 1
Afragola 1
Almaty 1
Athens 1
Auckland 1
Avellino 1
Totale 4.475
Salva come PNG Salva come JPEG
Nome #
Cannabinoid receptor 2-63 QQ varianti s associated with severe necroinflammation in chronic epatiti C 114
Hepatocellular carcinoma in chronic HBV-HCV co-infection is correlated to fibrosis and disease duration 93
Abdominal fat interacts with PNPLA3 I148M, but not with the APOC3 variant in the pathogenesis of liver steatosis in chronic hepatitis C 87
Hepatitis B virus, hepatitis C virus and human immunodeficiency virus infection in undocumented migrants and refugees in southern Italy, January 2012 to June 2013 83
Association Between a Polymorphism in Cannabinoid Receptor 2 and Severe Necroinflammation in Patients With Chronic Hepatitis C. 81
Functional interplay between hepatitis B virus X protein and human miR-125a in HBV infection 80
Liver microRNA hsa-miR-125a-5p in HBV Chronic Infection: Correlation with HBV Replication and Disease Progression 77
Acute hepatitis with severe cholestasis and prolonged clinical course due to hepatitis A virus Ia and Ib coinfection 76
The reactivation of occult HBV infection emerging with the case of acute hepatitis B in the wife of a subject treated with rituximab-based chemotherapy 68
Cannabinoid Receptor 2 (CB2) Q63 variant in chronic hepatitis C: an association with a more severe hepatocellular necrosis. 62
Role of interleukin 28-B in the spontaneous and treatment-related clearance of HCV infection in patients with chronic HBV/HCV dual infection 61
Characteristics of liver cirrhosis in Italy: Evidence for a decreasing role of HCV aetiology. 61
Peg-interferon plus ribavirin with or without boceprevir or telaprevir for HCV genotype 1: a meta-analysis on the role of response predictors 60
Abstracts of the 63rd Annual Meeting of the American Association for the Study of Liver Diseases. November 9-13, 2012. Boston, Massachusetts, USA. 60
416 molecular analysis of genetic variability and epitope stability in a type 1B recurrent HCV infection 60
Cannabinoid receptor 2 (CB2) Q63 variant is associated with a severe histological activity index in patients with chronic hepatitis C 60
579 CHANGING PATTERN OF HBV GENOTYPES IN ITALY 58
P.216 Molecular analysis of genetic variability and epitope stability in a type 1b recurrent HCV infection 57
733 REACTIVATION OF OVERT AND OCCULT HBV INFECTION IN IMMUNOSUPPRESSIVE SETTINGS Journal of Hepatology 56
Acute hepatitis C: clinical and laboratory diagnosis, course of the disease, treatment 55
HBV transmission from an occult carrier with five mutations in the major hydrophilic region of HBsAg to an immunosuppressed plasma recipient 55
Infezione da HBV in soggetti immigrati: risultati preliminari di uno studio prospettico multicentrico 54
Absence of occult HCV infection in HIV-positive patients 54
540 IDENTIFICATION OF LAMIVUDINE RESISTANT HBV STRAIN RT204V/I IN ACUTE HEPATITIS B IN ITALY 54
Epidemiology of HCV and HBV in a High Endemic Area of Southern Italy: Opportunities from the COVID-19 Pandemic—Standardized National Screening or One Tailored to Local Epidemiology? 53
Eighteen-month lamivudine prophylaxis on preventing occult hepatitis B virus infection reactivation in patients with haematological malignancies receiving immunosuppression therapy 53
The impact of viral molecular diversity on the clinical presentation and outcome of acute hepatitis B in Italy. 51
Clinical and virological characteristics associated with severe acute hepatitis B 51
Liver biopsy in chronic hepatitis C: the experience of 15 Italian wards of infectious diseases. 51
Tm6sf2 e167k variant is associated with severe steatosis in chronic hepatitis c, regardless of pnapl3 polymorphism 51
The TM6SFZ 8167K variant is an independent predictor of severe liver steatosis in chronic hepatitis C 50
No effect of MTP polymorphisms on PNPLA3 in HCV-correlated steatosis 50
Role of genetic polymorphisms in hepatitis C virus chronic infection 48
RITUXIMAB-BASED TREATMENT, HCV REPLICATION AND HEPATIC FLARES 47
Hepatitis B virus infection in undocumented immigrants and refugees in Southern Italy: demographic, virological, and clinical features 47
Improvement in the aetiological diagnosis of acute hepatitis C: a diagnostic protocol based on the anti-HCV-IgM titre and IgG Avidity Index. 46
Factors affecting the changes in molecular epidemiology of acute hepatitis B in a Southern Italian area. 45
Sustained virological response to antiviral treatment in chronic hepatitis C patients may be predictable by HCV-RNA clearance in peripheral blood mononuclear cells 45
Clinical Presentation, Outcomes, and Response to Therapy Among Patients with Acute Exacerbation of Chronic Hepatitis C. 45
T-14 Virological and clinical impact of anti-HBV nucleos(t)ide analogues in cirrhotic patients with HBV-HCV coinfection 45
F-6 Efficacy and tolerability of peginterferon a-2a and a-2b in patients with chronic hepatitis C by genotype 1: A meta-analysis 45
Changes in HBV molecular epidemiology in acute hepatitis B in neapolitan are: a consequence of HBV mass vaccination and increase immigration. 45
Occult HBV infection in the oncohematological setting. 45
Blood-borne chronic viral infections in a large cohort of immigrants in southern Italy: A seven-centre, prospective, screening study 45
P.403 Clinical and virological improvement of HBV or HCV related chronic hepatitis with concomitant HAV infection 44
P1896 Relationship between virological evolution and acute exacerbation of chronic hepatitis C (A–E–CHC) and during the natural history of infection 44
Polimorfismo di IL28b nei soggetti con infezione cronica da HCV con transaminasi persistentemente normali e nei pazienti con epatite cronica da HCV 43
Role of ITPA and IL28B variants in the management of chronic hepatitis C treatment 43
HBV superinfection in HCV chronic carriers is associated with severe acute hepatitis and clearance of HCV chronic infection. 42
Caratteristiche virologiche e cliniche dell’epatite acuta A in soggetti con infezione cronica da HBV e da HCV. 42
Absence of occult HCV infection in patients experiencing an immunodepression condition 42
Efficacy of pegylated interferon alpha-2a AND alpha-2b in patients with genotype 1 chronic Hepatitis C: a meta-analysis 41
Lamivudine-resistant HBV strain rtM204V/I in acute hepatitis B 41
FATTORI ASSOCIATI ALLA PRESENTAZIONE CLINICA DELL’INFEZIONE CRONICA DA HCV 41
Hepatitis B virus in immigrant population 41
Clinical findings of HCV chronic infection in undocumented immigrants and low-income refugees in three areas of southern Italy 41
Low prevalence of HTLV1/2 infection in a population of immigrants living in southern Italy 41
HBV molecular epidemiology and clinical condition of immigrants living in Italy 41
More Severe COVID-19 in Patients With Active Cancer: Results of a Multicenter Cohort Study 40
An estimation of the prevalence of occult HBV infection in Western Europe and in Northern America: A meta-analysis 39
ACUTE EXACERBATION OF CHRONIC HEPATITIS C: CLINICAL PRESENTATION, OUTCOME AND RESPONSE TO ANTI-HCV TREATMENT 39
Directly acting antiviral-based treatment for hcv-infected persons who inject drugs: A multicenter real-life study 39
Uso combinato del titolo delle IgM anti-HCV e dell’indice di avidità delle IgG anti-HCV per la diagnosi di epatite acuta C. 38
Analisi dell’evoluzione virologica ed epitopica dell’infezione da virus C:dall’epatite acuta ad episodi di epatonecrosi acuta HCV correlata. 38
Multiple Hepatitis B Virus (HBV) Quasispecies and Immune-Escape Mutations Are Present in HBV Surface Antigen and Reverse Transcriptase of Patients With Acute Hepatitis B 38
Acute hepatitis C: Clinical and laboratory diagnosis, course of the disease, treatment 38
A HIGH GENETIC HETEROGENEITY IN HBsAg CAN AFFECT IMMUNOGENICITY IN ACUTE HEPATITIS B INFECTION 38
Epatite acuta da HAV con decorso clinico severo e prolungato causato da co-infezione da sottotipi virali Ia ed Ib. 38
Virological and epitope evolution of HCV infection from acute hepatitis C to subsequent episodes of HCV-related acute liver cell necrosis. 37
Role of occult hepatitis B virus infection in chronic hepatitis C 37
HBV superinfection in HCV chronic carriers is associated with severe acute hepatitis and clearance of HCV chronic replication 36
RISK OF FAILURE IN DUAL THERAPY VERSUS TRIPLE THERAPY IN NAÏVE HIV-PATIENTS: A META-ANALYSIS 36
Molecular epidemiology of hepatitis B virus genotypes circulating in acute hepatitis B patients in the Campania region. 35
Hepatitis c virus markers in infection by hepatitis c virus:In the era of directly acting antivirals 35
Patients with HCV genotype-1 who have failed a direct-acting antiviral regimen: virological characteristics and efficacy of retreatment 35
Virological and clinical impact of anti-HBV nucleos(t)ide analogues in cirrhotic patients with HBV-HCV coinfection 34
OC-34 HCV replication in patients with onco-haematological diseases 34
Treatment of chronic hepatitis C in patients with HIV/HCV coinfection. 34
A STRATEGY TO FAVOR THE ACCESS OF IRREGULAR AND REFUGEE MIGRANTS TO A SCREENING PROGRAM FOR HBV, HCV AND HIV INFECTION 34
A HIGH HBSAG GENETIC COMPLEXITY CAN INFLUENCE HBV IMMUNOGENICITY IN THE SETTING OF ACUTE INFECTION 34
A STRATEGY TO FAVOR THE ACCESS OF IRREGULAR AND REFUGEE MIGRANTS TO A SCREENING PROGRAM FOR HBV, HCV AND HIV INFECTION 34
Impact of DAA-Based Regimens on HCV-Related Extra-Hepatic Damage: A Narrative Review 34
Risk and prevention of hepatitis b virus reactivation during immunosuppression for non-oncological diseases 34
Identification Of Lamivudine resistant HBV strain rt204V/I in Acute Hepatitis B in Italy 32
Etiological factors of chronic hepatitis in Italy: a 2014 national survey 32
Influence of universal HBV vaccination on chronic HBV infection in Italy: Results of a cross-sectional multicenter study 32
Direct acting antivirals treatment for hepatitis C virus infection does not increase the incidence of de novo hepatocellular carcinoma occurrence: Results from an Italian real-life cohort (LINA cohort) 32
Efficacy of 12-weeks velpatasvir plus sofosbuvir-based regimen in HCV-naive subjects with mild fibrosis: A meta-analysis 32
CANNABINOID RECEPTOR 2 (CB2) 63 QQ VARIANT IS ASSOCIATED WITH A SEVERE HISTOLOGICAL ACTIVITY INDEX IN PATIENTS WITH CHRONIC HEPATITIS C 32
Absence of occult HCV infection in HIV-positive patients 32
Acute hepatitis with severe cholestasis and prolonged clinical course due to hepatitis A virus Ia and Ib coinfection 32
Characteristics and Changes over Time of Alcohol-Related Chronic Liver Diseases in Italy 32
Mortality and risk factors of vaccinated and unvaccinated COVID-19 frail patients treated with anti-SARS-CoV-2 monoclonal antibodies. A real-world study 31
HBV Superinfection in HCV Chronic Carriers: A Disease That Is Frequently Severe but Associated with the Eradication of HCV 31
Clinical Presentation, Outcome, and Response to Therapy Among Patients With Acute Exacerbation of Chronic Hepatitis C 31
Hepatitis C late relapse in patients with directly acting antiviral-related sustained virological response at week 12 31
Clinical applications of antibody avidity and IgM testing in acute HCV infection 30
Rituximab-based chemotherapy in HCV positive patients with Onco-Haematological diseases enhances HCV replication and is followed by an hepatic flare 30
Liver fibrosis in human immunodeficiency virus/hepatitis C virus coinfection: Diagnostic methods and clinical impact 30
The association between education level and chronic liver disease of any etiology 30
Totale 4.611
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.269
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.269
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020304 0 0 0 0 84 11 99 27 40 20 19 4
2020/2021707 63 2 77 34 112 18 92 79 17 109 88 16
2021/2022917 35 15 2 8 210 13 105 11 23 84 66 345
2022/20232.145 194 56 27 115 300 127 2 102 1.132 15 37 38
2023/2024992 68 23 73 68 351 116 16 26 11 11 49 180
2024/2025634 9 39 16 87 483 0 0 0 0 0 0 0
Totale 6.543